Anavex Life Sciences (AVXL) Enterprise Value Growth (1y) (2011 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Anavex Life Sciences | 266.20 Mn | 134.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -9.09% |
| Sep 30, 2025 | 22.40% |
| Jun 30, 2025 | 27.09% |
| Mar 31, 2025 | 16.94% |
| Dec 31, 2024 | 15.99% |
| Sep 30, 2024 | 12.47% |
| Jun 30, 2024 | 10.37% |
| Mar 31, 2024 | 9.18% |
| Dec 31, 2023 | -0.10% |
| Sep 30, 2023 | -1.25% |
| Jun 30, 2023 | -1.06% |
| Mar 31, 2023 | -0.08% |
| Dec 31, 2022 | 4.98% |
| Sep 30, 2022 | 1.94% |
| Jun 30, 2022 | 2.77% |
| Mar 31, 2022 | -102.14% |
| Dec 31, 2021 | -219.16% |
| Sep 30, 2021 | -420.04% |
| Jun 30, 2021 | -470.47% |
| Mar 31, 2021 | -185.58% |
| Dec 31, 2020 | -72.47% |
| Sep 30, 2020 | -31.84% |
| Jun 30, 2020 | -29.89% |
| Mar 31, 2020 | -36.41% |
| Dec 31, 2019 | -32.28% |
| Sep 30, 2019 | 3.25% |
| Jun 30, 2019 | 17.67% |
| Mar 31, 2019 | 24.10% |
| Dec 31, 2018 | 25.99% |
| Sep 30, 2018 | 16.43% |
| Jun 30, 2018 | -4.17% |
| Mar 31, 2018 | -9.87% |
| Dec 31, 2017 | -32.55% |
| Sep 30, 2017 | -198.69% |
| Jun 30, 2017 | -154.89% |
| Sep 30, 2016 | 39.92% |
| Jun 30, 2016 | -22.18% |
| Sep 30, 2015 | -110.56% |
| Jun 30, 2015 | 2.67% |
| Mar 31, 2015 | 31.36% |
| Dec 31, 2014 | -7,177.33% |
| Sep 30, 2014 | -2,004.52% |
| Jun 30, 2014 | -497,145.05% |
| Mar 31, 2014 | -1,887,694.25% |
| Dec 31, 2013 | -20.23% |
| Sep 30, 2013 | -2,937.09% |
| Jun 30, 2013 | 90.96% |
| Mar 31, 2013 | 99.73% |
| Dec 31, 2012 | -778.83% |
| Sep 30, 2012 | 91.57% |
| Jun 30, 2012 | 98.51% |
| Mar 31, 2012 | -4,806.54% |
| Sep 30, 2011 | 49.11% |